|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
1977-7-18
|
|
pubmed:abstractText |
The percutaneous absorption of betamethasone-17, 21-dipropionate and salicylic acid was studied after one and two weeks' treatment of psoriaris and eczema. The treated areas varied between 8 and 41 dm2. No change in the plasma cortisol levels was detectable by the routinely used laboratory method. The treatment gave no detectable salicylate concentrations in plasma.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
0300-0605
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
4
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
106-10
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:799983-Administration, Topical,
pubmed-meshheading:799983-Adolescent,
pubmed-meshheading:799983-Adult,
pubmed-meshheading:799983-Aged,
pubmed-meshheading:799983-Betamethasone,
pubmed-meshheading:799983-Clinical Trials as Topic,
pubmed-meshheading:799983-Eczema,
pubmed-meshheading:799983-Female,
pubmed-meshheading:799983-Humans,
pubmed-meshheading:799983-Hydrocortisone,
pubmed-meshheading:799983-Male,
pubmed-meshheading:799983-Middle Aged,
pubmed-meshheading:799983-Psoriasis,
pubmed-meshheading:799983-Salicylates,
pubmed-meshheading:799983-Salicylic Acids,
pubmed-meshheading:799983-Skin Absorption,
pubmed-meshheading:799983-Time Factors
|
|
pubmed:year |
1976
|
|
pubmed:articleTitle |
Percutaneous absorption of betamethasone-17, 21-dipropionate and salicylic acid during the treatment of psoriasis and eczema.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial
|
